Organization Profile

You just read:

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Primary Peritoneal Cancer

News provided by

Oncolytics Biotech Inc.

Mar 03, 2015, 06:30 ET